Elizabeth DeVita-Raeburn is a New York-based writer who specializes in science, health and medicine. She is the author of The Death of Cancer and The Empty Room. She lives in New York City, with her husband, the writer Paul Raeburn, and two sons.
Elizabeth DeVita-Raeburn
From this contributor
The controversy over autism’s most common therapy
Applied behavioral analysis is the most widely used therapy for autism, but some people say its drills and routines are cruel, and its aims misguided.
The controversy over autism’s most common therapy
By
Elizabeth DeVita-Raeburn
10 August 2016 | 20 min read
Explore more from The Transmitter
Securing the academic pipeline amid uncertain U.S. funding climate
Finding creative ways to keep early-career researchers in academia—for example, through part-time roles—can help the field weather the storm.
Securing the academic pipeline amid uncertain U.S. funding climate
Finding creative ways to keep early-career researchers in academia—for example, through part-time roles—can help the field weather the storm.
By
Lucina Q. Uddin
9 March 2026 | 4 min read
Let’s teach neuroscientists how to be thoughtful and fair reviewers
Blanco-Suárez revamped the traditional journal club by developing a course in which students peer review preprints alongside the published papers that evolved from them.
Let’s teach neuroscientists how to be thoughtful and fair reviewers
Blanco-Suárez revamped the traditional journal club by developing a course in which students peer review preprints alongside the published papers that evolved from them.
By
Elena Blanco-Suárez
6 March 2026 | 6 min read
New autism committee positions itself as science-backed alternative to government group
The Independent Autism Coordinating Committee plans to meet at the same time as the U.S. federal Interagency Autism Coordinating Committee later this month—and offer its own research agenda.
New autism committee positions itself as science-backed alternative to government group
The Independent Autism Coordinating Committee plans to meet at the same time as the U.S. federal Interagency Autism Coordinating Committee later this month—and offer its own research agenda.
By
Angie Voyles Askham
5 March 2026 | 5 min read